Skip to content
Stephen H. Rappaport

Stephen H. Rappaport

Contact

Credentials

Residency & Fellowship

Critical Care Pharmacy Residency - The University of Vermont Medical Center, Burlington, VT (American Society of Health System Pharmacists Accredited) 2015 - 2016

Pharmacy Practice Residency - University of Connecticut Health Center, Farmington, CT (American Society of Health System Pharmacists Accredited) 2012 - 2013

Education

Doctor of Pharmacy | University of Pittsburgh School of Pharmacy. Pharmacy. 2009

Awards

SCCM Presidential Citation. 2024

Fellow of Critical Care Medicine. 2024

SCCM Presidential Citation. 2022

NYS ACCP Educator of the Year. 2019

Critical Care PRN Resident Research Grant. 2015

ASHP Foundation Pharmacy Resident Practice-Based Research Grant. 2012

Publications

Journal Articles

Effect of Inpatient Pharmacist-Led Medication Reconciliations on Medication-Related Interventions in Intensive Care Unit Recovery Centers.

Singer SK, Betthauser KD, Barber AE, Bookstaver Korona R, Dixit D, Groth CM, Kenes MT, MacTavish P, Kruer RM, McDaniel CM, McIntire AM, Miller E, Mohammad RA, Poyant JO, Rappaport SH, Whitten JA, A Yeung SY, Stollings JL

Hospital pharmacy.. 2024 December 59 (6):650-659. Epub 08/07/2024.

An international, multicenter post hoc analysis comparing in-person and virtual medication management strategies in post-ICU recovery clinics.

Beaudrie-Nunn AN, Poyant JO, Groth CM, Rappaport SH, Kruer RM, Miller E, Whitten JA, Mcintire AM, McDaniel CM, Betthauser KD, Mohammad RA, Mohammad RA, Bookstavar Korona R, Barber AE, MacTavish P, Dixit D, Yeung SYA, Stollings JL

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.. 2024 August 20 Epub 08/20/2024.

Practices and Outcomes Associated With Sublingual Buprenorphine Use in a Critically Ill Population.

Vanini DJ, Corvelli JM, Maynard KM, Rappaport SH, Grasso G, Jones R, Acquisto NM, Schult RF

Critical care explorations.. 2024 March 6 (3):e1062. Epub 03/12/2024.

Determining the Risk of Elevated Digoxin Concentrations Following Loading Dose in Patients With Acute and Chronic Kidney Disease.

Young MR, Rappaport SH, Belz S, Kaufman DC, Haas CE

The Annals of pharmacotherapy.. 2024 January 58 (1):37-43. Epub 04/12/2023.

An International, Multicenter Evaluation of Comprehensive Medication Management by Pharmacists in ICU Recovery Centers.

Stollings JL, Poyant JO, Groth CM, Rappaport SH, Kruer RM, Miller E, Whitten JA, Mcintire AM, McDaniel CM, Betthauser KD, Mohammad RA, Kenes MT, Korona RB, Barber AE, MacTavish P, Dixit D, Yeung SYA

Journal of intensive care medicine.. 2023 October 38 (10):957-965. Epub 05/17/2023.

Low-dose Initiation of Buprenorphine in Hospitalized Patients on Full Agonist Opioid Therapy: A Retrospective Observational Study.

Schult RF, Maynard KM, Corvelli JM, Rappaport S, McKinney B, Clarkson T, Wiegand TJ, Malcho J, Acquisto NM

Journal of addiction medicine.. 2023 August 18 Epub 08/18/2023.

Lanthanum masquerading as foreign body ingestion in a critically ill patient with end-stage renal disease.

Rappaport SH, Vineyard T, Hack M, Shah T, Dooley JW

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.. 2023 March 2180 (7):430-434. Epub 1900 01 01.

Retrospective evaluation of chemical venous thromboembolism prophylaxis in traumatic brain injury

Hollfelder EK, Rappaport S, Cheng J, Patel JH.

Surgery in Practice and Science. 2023; 13(100168).

A Retrospective Characterization of Dexmedetomidine-Suspected Fever and Its Consequences in Adult Critically Ill Patients.

Schranz E, Rappaport S, Groth C, Prasad P, Cooper K, Connor K

The Annals of pharmacotherapy.. 2022 September 56 (9):1023-1029. Epub 01/06/2022.

Characterization of Intravenous Ethanol Use for AlcoholDependent Patients in an Intensive Care Unit

Polito NB, Rappaport S, Cooper KC, Connor KA, Valentino M, Prasad P.

Asia Pac J Med Toxicol. 2022; 12(1): 10-15.

Predictors of Serious Opioid-Related Adverse Drug Events in Hospitalized Patients.

Minhaj FS, Rappaport SH, Foster J, Gashlin LZ

Journal of patient safety.. 2021 December 117 (8):e1585-e1588. Epub 1900 01 01.

Venous thromboembolism associates with SARS-CoV-2 more than seasonal influenza.

Lachant D, Roto D, Rappaport S, Prasad P, Lachant N, White RJ

Thrombosis research.. 2021 September 205 :40-43. Epub 07/03/2021.

Anti-FXa Activity with Intermediate-Dose Thromboprophylaxis in COVID-19.

Rappaport SH, Clark JM, Delibert S, Maynard KM, Prasad P, Kaufman DC, Pietropaoli AP, Quill CM, Groth CM

American journal of respiratory and critical care medicine.. 2020 December 15202 (12):1731-1733. Epub 1900 01 01.

Chronic therapeutic anticoagulation is associated with decreased thrombotic complications in SARS-CoV-2 infection.

Lachant DJ, Lachant NA, Kouides P, Rappaport S, Prasad P, White RJ

Journal of thrombosis and haemostasis : JTH.. 2020 October 18 (10):2640-2645. Epub 08/24/2020.

A Retrospective Study of Early vs Delayed Home Dose Basal Insulin in the Acute Management of Diabetic Ketoacidosis.

Rappaport SH, Endicott JA, Gilbert MP, Farkas JD, Clouser RD, McMillian WD

Journal of the Endocrine Society.. 2019 May 13 (5):1079-1086. Epub 04/11/2019.